Global medical technology company will use Anaqua’s AQX to help consolidate and coordinate the management of all its IP assets
BOSTON, June 06, 2023 (GLOBE NEWSWIRE) — Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced that global medical technology company Getinge has selected Anaqua’s AQX in order to consolidate the management of all its IP assets onto a single, centralized platform.
Founded in Sweden in 1904, Getinge provides hospitals and life science institutions in 133 countries with products and solutions that aim to improve clinical results and optimize workflows.
Anna Maria Lagerqvist Gahm, Head of IP & Digital Law at Getinge, said: “With our extensive range of products and solutions for intensive care, cardiova...
Ai-Media at BroadcastAsia 2023 in Singapore
Ai-Media at BroadcastAsia 2023 in Singapore, June 7-9
SYDNEY, Australia, June 06, 2023 (GLOBE NEWSWIRE) — Ai-Media, the leader in technology-driven live captioning, transcription, and translation solutions, is excited to announce its presence at BroadcastAsia in Singapore, where it will unveil its ground-breaking LEXI 3.0 automatic captioning solution to the Asian market.
Previously launched to the North American market at NAB Show 2023, LEXI 3.0 is the new and improved version of Ai-Media’s flagship automatic captioning solution. Powered by AI, LEXI 3.0 is the world’s most accurate and advanced automatic captioning solution, delivering results that rival human captions at a fraction of the cost.
During the BroadcastAsia, Ai-Media ...
The Road to Autonomy – Executive Summary
VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE CANADA:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in the next generation of artificial intelligence (“AI”), announces the release in June 2023 of an AI industry report titled “THE ROAD TO AUTONOMY: A Path To Global AI Governance”.
The report combines the legislative expertise from Dentons, the world’s largest multinational law firm, and the AI acumen of VERSES with the guidance on technical standards from the Spatial Web Foundation to provide an in-depth analysis of the legal and key legislative trends from across the world on the state of AI regulation and recommendations...
DUBAI, UNITED ARAB EMIRATES – Media OutReach – 5 June 2023 – Bybit, the world’s third most visited crypto exchange, has announced a strategic partnership with the leading global business district, the Dubai Multi Commodities Centre (DMCC) to accelerate the mass adoption of crypto in Dubai and deliver on its promise of investing in the Web3 ecosystem in the emirate. The collaboration will see Bybit become an official Ecosystem Partner for the DMCC Crypto Centre, the largest concentration of crypto and Web3 businesses in the MENA region.Bybit and DMCC signed a Memorandum of Understanding (MOU) to support the growth of the crypto community in the region. The agreement follows the unveiling of Bybit’s global headquarters in Dubai on April 17 when it alluded to further locali...
Zoom IQ meeting summary and chat compose features allow users to quickly summarize Zoom Meetings without recording and draft content in Zoom Team Chat
SAN JOSE, Calif., June 05, 2023 (GLOBE NEWSWIRE) — Today Zoom Video Communications, Inc. (NASDAQ: ZM) launched key features of Zoom IQ, a smart companion that empowers collaboration and unlocks people’s potential through generative AI. Now available through free trials for customers in select plans,1 the Zoom Meeting summary and Zoom Team Chat compose features will help teams improve productivity, balance workday priorities, and collaborate more effectively.
“With the introduction of these new capabilities in Zoom IQ, an incredible generative AI assistant, teams can further enhance their productivity for everyday tasks, freeing up ...
NRx Pharmaceuticals, Lotus Pharmaceuticals, and Alvogen to collaborate on the further development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets
Lotus Pharmaceuticals will acquire worldwide rights for NRX-101 for S-TRBD and will be responsible for commercialization of NRX-101 in markets outside the US through Lotus’s direct presence in certain Asian markets or through their export division, which currently has partnerships in numerous markets, including in Europe, Japan, China, Australia and Latin America
Alvogen, through its CNS focused Almatica® division, will be responsible for U.S. commercialization of NRX-101
NRx will be eligible to receive up to $330 million in milestone payments tied to development progress and sal...